Over the years most practicing cardiologists have mobilized multiple drugs at the lower dosages

instead of increasing the dosage of a single drug to the maximum whenever hypertension is not

satisfactorily controlled with a single agent, i.e. practicing polypharmacy because the BP is better

controlled with less chance of bringing on side effects.

This study is the further test of the concept of the polypharmacy, I believe.